Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-114422
Filing Date
2024-10-11
Accepted
2024-10-11 20:00:04
Documents
1
Period of Report
2024-10-11

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5154
  Complete submission text file 0000950170-24-114422.txt   6900
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Issuer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O WAVE LIFE SCIENCES LTD. 733 CONCORD AVE. CAMBRIDGE MA 02138
Business Address
Moran Kyle (Reporting) CIK: 0001657765 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37627 | Film No.: 241368737